Literature DB >> 21145375

Modelling patterns of clearance of HPV-16 infection and vaccination efficacy.

Iacopo Baussano1, Geoff Garnett, Nereo Segnan, Guglielmo Ronco, Paolo Vineis.   

Abstract

A model representing carcinogenic HPV infection transmission dynamics and cervical cancer natural history was adapted to assess the consequences of introducing vaccination against HPV-16 infection. Alternative scenarios either allowing repeated infections with the HPV-16 (i.e. SIS scenario) or assuming that clearance of infection occurs through the development of a long lasting, specific immune response which protects against re-infection (i.e. SIR scenario) were investigated. The difference in reduction in lifetime cervical cancer achieved through vaccination of 12-year-old girls, between SIS and SIR scenarios, was up to 25% of expected cases in an unscreened population. This difference increased to 30% when vaccination of 12-year-old boys was also included as an intervention. The role of SIS or SIR dynamics should be accounted for in the assessment of model-based projections of the effectiveness of vaccination programmes, until available data about the transmission dynamics support the accuracy of model predictions. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21145375     DOI: 10.1016/j.vaccine.2010.11.082

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

1.  Regional variations in HPV vaccination among 9-17 year old adolescent females from the BRFSS, 2008-2010.

Authors:  Jacqueline M Hirth; Mahbubur Rahman; Jennifer S Smith; Abbey B Berenson
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 2.  A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus.

Authors:  Yiling Jiang; Aline Gauthier; Maarten J Postma; Laureen Ribassin-Majed; Nathalie Largeron; Xavier Bresse
Journal:  Hum Vaccin Immunother       Date:  2013-07-23       Impact factor: 3.452

3.  Randomized controlled trial of two dosing schedules for human papillomavirus vaccination among college age males.

Authors:  Chyongchiou Jeng Lin; Richard K Zimmerman; Mary Patricia Nowalk; Hsin-Hui Huang; Jonathan M Raviotta
Journal:  Vaccine       Date:  2013-12-14       Impact factor: 3.641

Review 4.  Modeling preventative strategies against human papillomavirus-related disease in developed countries.

Authors:  Karen Canfell; Harrell Chesson; Shalini L Kulasingam; Johannes Berkhof; Mireia Diaz; Jane J Kim
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

5.  Causal diagrams in systems epidemiology.

Authors:  Michael Joffe; Manoj Gambhir; Marc Chadeau-Hyam; Paolo Vineis
Journal:  Emerg Themes Epidemiol       Date:  2012-03-19

6.  Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior.

Authors:  Iacopo Baussano; Fulvio Lazzarato; Marc Brisson; Silvia Franceschi
Journal:  Emerg Infect Dis       Date:  2016-01       Impact factor: 6.883

7.  Type-specific human papillomavirus biological features: validated model-based estimates.

Authors:  Iacopo Baussano; K Miriam Elfström; Fulvio Lazzarato; Anna Gillio-Tos; Laura De Marco; Francesca Carozzi; Annarosa Del Mistro; Joakim Dillner; Silvia Franceschi; Guglielmo Ronco
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

8.  The impact of HPV female immunization in Italy: model based predictions.

Authors:  Giorgio Guzzetta; Luca Faustini; Donatella Panatto; Roberto Gasparini; Piero Manfredi
Journal:  PLoS One       Date:  2014-03-11       Impact factor: 3.240

9.  Vaccination Programs for Endemic Infections: Modelling Real versus Apparent Impacts of Vaccine and Infection Characteristics.

Authors:  Romain Ragonnet; James M Trauer; Justin T Denholm; Nicholas L Geard; Margaret Hellard; Emma S McBryde
Journal:  Sci Rep       Date:  2015-10-20       Impact factor: 4.379

10.  Inference of type-specific HPV transmissibility, progression and clearance rates: a mathematical modelling approach.

Authors:  Helen C Johnson; K Miriam Elfström; W John Edmunds
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.